Shruti Dave

1.0k total citations
30 papers, 704 citations indexed

About

Shruti Dave is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Shruti Dave has authored 30 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Genetics. Recurrent topics in Shruti Dave's work include Pancreatic function and diabetes (14 papers), Mesenchymal stem cell research (9 papers) and Diabetes Management and Research (9 papers). Shruti Dave is often cited by papers focused on Pancreatic function and diabetes (14 papers), Mesenchymal stem cell research (9 papers) and Diabetes Management and Research (9 papers). Shruti Dave collaborates with scholars based in India, Germany and United States. Shruti Dave's co-authors include Hargovind L. Trivedi, Aruna V. Vanikar, Umang G. Thakkar, S. Chooramani Gopal, Tulika Chandra, Varsha B. Trivedi, Hugo Kaneku, Matthew J. Everly, Paul I. Terasaki and A Feroz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and Advances in experimental medicine and biology.

In The Last Decade

Shruti Dave

30 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shruti Dave India	13	416	279	187	132	129	30	704
P. W. Thompson United Kingdom	18	399 1.0×	26 0.1×	261 1.4×	204 1.5×	69 0.5×	28	974
Mahdokht Hossein Aghdaei Iran	13	136 0.3×	88 0.3×	94 0.5×	18 0.1×	50 0.4×	35	370
Heloisa Cristina Caldas Brazil	12	116 0.3×	95 0.3×	208 1.1×	35 0.3×	34 0.3×	40	461
Shuhei Nakaji Japan	17	327 0.8×	56 0.2×	218 1.2×	87 0.7×	4 0.0×	35	622
Marc Winslet United Kingdom	17	249 0.6×	26 0.1×	234 1.3×	34 0.3×	8 0.1×	38	722
Sharon C. Lehec United Kingdom	16	829 2.0×	81 0.3×	184 1.0×	14 0.1×	11 0.1×	25	1.0k
S. Post Germany	15	202 0.5×	12 0.0×	224 1.2×	41 0.3×	25 0.2×	45	648
Xiaohu Fan Canada	13	166 0.4×	9 0.0×	223 1.2×	53 0.4×	99 0.8×	18	596
J Živný Czechia	14	56 0.1×	94 0.3×	333 1.8×	61 0.5×	4 0.0×	40	671
Veronika Jekerle Netherlands	8	136 0.3×	201 0.7×	208 1.1×	42 0.3×	2 0.0×	11	552

Countries citing papers authored by Shruti Dave

Since Specialization

Citations

This map shows the geographic impact of Shruti Dave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shruti Dave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shruti Dave more than expected).

Fields of papers citing papers by Shruti Dave

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shruti Dave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shruti Dave. The network helps show where Shruti Dave may publish in the future.

Co-authorship network of co-authors of Shruti Dave

This figure shows the co-authorship network connecting the top 25 collaborators of Shruti Dave. A scholar is included among the top collaborators of Shruti Dave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shruti Dave. Shruti Dave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jan, Yih‐Kuen, et al.. (2024). Diagnosis, Pathophysiology and Management of Microvascular Dysfunction in Diabetes Mellitus. Diagnostics. 14(24). 2830–2830. 5 indexed citations

Guleria, Sandeep, Sunita Agarwal, Manisha Sahay, et al.. (2022). ISOT consensus statement for the kidney transplant recipient and living donor with a previous diagnosis of COVID-19. Indian Journal of Nephrology. 32(4). 288–288. 2 indexed citations

Guleria, Sandeep, Anil Kumar Bhalla, Ashish Sharma, et al.. (2021). ISOT Consensus Statement for the Kidney Transplant Recipient and Living Donor with a Previous Diagnosis of COVID-19. SHILAP Revista de lepidopterología. 15(2). 131–133. 9 indexed citations

Dave, Shruti, et al.. (2017). In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?. Current Stem Cell Research & Therapy. 12(4). 288–299. 2 indexed citations

Thakkar, Umang G., Hargovind L. Trivedi, Aruna V. Vanikar, & Shruti Dave. (2015). Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow–derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. Cytotherapy. 17(7). 940–947. 102 indexed citations

Vanikar, Aruna V., Hargovind L. Trivedi, Ashutosh Kumar, et al.. (2014). Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation – single center experience. Renal Failure. 36(9). 1376–1384. 23 indexed citations

Dave, Shruti, Hargovind L. Trivedi, S. Chooramani Gopal, & Tulika Chandra. (2014). Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells’ infusion for patients with insulin-dependent diabetes. BMJ Case Reports. 2014. bcr2013201238–bcr2013201238. 9 indexed citations

Dave, Shruti. (2014). Mesenchymal stem cells derived in vitro transdifferentiated insulin-producing cells: A new approach to treat type 1 diabetes. SHILAP Revista de lepidopterología. 3(1). 266–266. 20 indexed citations

Vanikar, Aruna V., Hargovind L. Trivedi, Pankaj R. Shah, et al.. (2013). Single-center experience on renal transplantation in primary focal and segmental glomerulosclerosis using hematopoietic stem cell transplantation in thymus, bone marrow, portal and peripheral circulation. Saudi Journal of Kidney Diseases and Transplantation. 24(1). 15–15. 8 indexed citations

10.

Vanikar, Aruna V., Hargovind L. Trivedi, S. Chooramani Gopal, Ashutosh Kumar, & Shruti Dave. (2013). Pre-transplant co-infusion of donor-adipose tissue derived mesenchymal stem cells and hematopoietic stem cells may help in achieving tolerance in living donor renal transplantation. Renal Failure. 36(3). 457–460. 10 indexed citations

11.

Dave, Shruti. (2013). Extrinsic Factors Promoting Insulin Producing Cell-Differentiation and Insulin Expression Enhancement-Hope for Diabetics.. Current Stem Cell Research & Therapy. 8(6). 471–483. 8 indexed citations

12.

Dave, Shruti, Aruna V. Vanikar, & Hargovind L. Trivedi. (2013). Extrinsic Factors Promoting In Vitro Differentiation of Insulin-Secreting Cells from Human Adipose Tissue-Derived Mesenchymal Stem Cells. Applied Biochemistry and Biotechnology. 170(4). 962–971. 21 indexed citations

13.

Dave, Shruti, Aruna V. Vanikar, Hargovind L. Trivedi, et al.. (2013). Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells. Clinical and Experimental Medicine. 15(1). 41–45. 45 indexed citations

14.

Dave, Shruti, Aruna V. Vanikar, & Hargovind L. Trivedi. (2013). Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease. BMJ Case Reports. 2013. bcr2013009901–bcr2013009901. 12 indexed citations

15.

Dave, Shruti, Aruna V. Vanikar, & Hargovind L. Trivedi. (2013). In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1. Cytotechnology. 66(2). 299–307. 16 indexed citations

16.

Dave, Shruti, Aruna V. Vanikar, Hargovind L. Trivedi, et al.. (2012). Stem Cells Versus Donor Specific Transfusions for Tolerance Induction in Living Donor Renal Transplantation. Transplantation. 95(1). 155–160. 11 indexed citations

17.

Thakkar, Umang G., et al.. (2011). Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells. BMJ Case Reports. 2011. bcr0720114436–bcr0720114436. 6 indexed citations

18.

Vanikar, Aruna V., et al.. (2010). Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness. International Urology and Nephrology. 43(1). 225–232. 27 indexed citations

19.

Trivedi, Hargovind L., Paul I. Terasaki, A Feroz, et al.. (2009). Abrogation of Anti-HLA Antibodies via Proteasome Inhibition. Transplantation. 87(10). 1555–1561. 129 indexed citations

20.

Trivedi, Hargovind L., Aruna V. Vanikar, Shruti Dave, et al.. (2008). Human Adipose Tissue-Derived Mesenchymal Stem Cells Combined With Hematopoietic Stem Cell Transplantation Synthesize Insulin. Transplantation Proceedings. 40(4). 1135–1139. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact